w

ON THE WEB

08/09/2018

Radioprotectors: Defensive Weapons In The War On Cancer

05/02/2018

EpicentRx Announces First Ever Treatment of Cancer Patient with Personalized, Custom-Made Viral Vaccines

05/02/2018

First Patient Treated With Next-Generation Immunotherapy at UC

02/19/2018

Will Immunotherapy Help Us Cure Lymphoma?

02/19/2018

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors

02/16/2018

The Currently Incurable Scientist: RRx-001 and the Impact of One CRC Patient-Chemist

01/08/2018

Leechburg woman leans on family as she battles neuroendocrine cancer

08/19/2015

EpicentRx Announces Publication of Phase 1 Trial Results for the Anti-Cancer Agent, RRx-001, in Lancet Oncology

11/17/2015

Reprogramming a Tumor for Death

RRx-001 DISCUSSIONS

Read about the ongoing discussions regarding RRx-001.
READ MORE